Homocystéine et risque cardiovasculaire: de l'utilité du dosage [Homocystein and cardiovascular risk: is dosage useful?]

Détails

ID Serval
serval:BIB_D7A7DA52B686
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Homocystéine et risque cardiovasculaire: de l'utilité du dosage [Homocystein and cardiovascular risk: is dosage useful?]
Périodique
Praxis
Auteur⸱e⸱s
Mathez C.h., Trueb L., Darioli R., Waeber G.
ISSN
1661-8157
Statut éditorial
Publié
Date de publication
2004
Volume
93
Numéro
50
Pages
2093-7
Langue
français
Notes
Publication types: English Abstract ; Journal Article - Publication Status: ppublish
Résumé
Hyperhomocysteinemia represents an independent risk factor for atherothrombotic disease. Physiopathological mechanisms of accelerated progression of atherosclerosis in presence of hyperhomocysteinemia are complex. Herein we report a clinical case which emphasis the importance of screening elevated homocystein in the absence of conventional risk factors in patients who suffer from premature atherosclerosis.
Mots-clé
Adult, Coronary Artery Disease, DNA Mutational Analysis, Heterozygote Detection, Homocysteine, Humans, Male, Methylenetetrahydrofolate Reductase (NADPH2), Myocardial Infarction, Protein S Deficiency, Prothrombin, Recurrence, Risk Factors, Thrombophilia
Pubmed
Création de la notice
28/01/2008 12:45
Dernière modification de la notice
14/03/2024 13:36
Données d'usage